Daclizumab to Treat HIV-Infected Patients

NCT00080431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Daclizumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)